Journal article
Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
Anticancer research, Vol.20(6D), pp.4995-4996
11/2000
PMID: 11326656
Abstract
Prostate-specific antigen (PSA) is the single most important tumor marker in early detection and monitoring of prostate cancer (CaP). However, routine analysis of serum PSA concentrations does not allow differentiation between CaP and prostatic diseases. The aim of the present study was to evaluate the usefulness of the serum-to-urinary PSA ratio in a clinical setting.
Details
- Title: Subtitle
- Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
- Creators
- M Hillenbrand - Department of Urology, Faculty of Medicine, University of Rostock, Ernst-Heydemann-Str. 6, D-18057 Rostock, GermanyM BastianM SteinerC ZinglerM MüllerJ M WolffH SeiterP Schuff-Werner
- Resource Type
- Journal article
- Publication Details
- Anticancer research, Vol.20(6D), pp.4995-4996
- Publisher
- Greece
- PMID
- 11326656
- ISSN
- 0250-7005
- eISSN
- 1791-7530
- Language
- English
- Date published
- 11/2000
- Academic Unit
- Stead Family Department of Pediatrics; Anesthesia
- Record Identifier
- 9984006338202771
Metrics
16 Record Views